EDGAR Filing Documents for 0001213900-15-003461

Form 8-K - Current report:

SEC Accession No. 0001213900-15-003461

Filing Date

2015-05-11

Accepted

2015-05-11 16:37:02

Documents

Period of Report

2015-04-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	f8k042015_yewbio.htm	8-K	26159
2	THE TRIPARTITE JOINT PLANTING AURICULARIA AURICULA CONTRACT	f8k042015ex10i_yewbio.htm	EX-10.1	29329
3	PRESS RELEASE	f8k042015ex99i_yewbio.htm	EX-99.1	10943
4	GRAPHIC	image_001.jpg	GRAPHIC	4021
	Complete submission text file	0001213900-15-003461.txt		73389

Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148

Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379

Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)